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Crystal structure of colicin E3 immunity protein: an inhibitor of a
ribosome-inactivating RNase
Chunmin Li1†‡, Dong Zhao1‡, Abdellah Djebli2 and Menachem Shoham1*
Background: Colicins are antibiotic-like proteins of Escherichia coli that kill
related strains. Colicin E3 acts as an RNase that specifically cleaves 16S rRNA,
thereby inactivating the ribosomes in the infected cell. The producing organism
is protected against colicin E3 by a specific inhibitor, the immunity protein Im3,
which forms a tight 1:1 complex with colicin E3 and renders it inactive.
Crystallographic studies on colicin E3 and Im3 have been undertaken to unravel
the structural basis for the ribonucleolytic activity and its inhibition. 
Results: The crystal structure of Im3 has been determined to a resolution of
1.8 Å. The structure consists of a four-stranded antiparallel β sheet flanked by
three α helices on one side of the sheet. Thr7, Phe9, Phe16 and Phe74 form
a hydrophobic cluster on the surface of the protein in the vicinity of Cys47.
This cluster is part of a putative binding pocket which also includes nine 
polar residues.
Conclusions: The putative binding pocket of Im3 is the probable site of
interaction with colicin E3. The six acidic residues in the pocket may interact
with some of the numerous basic residues of colicin E3. The involvement of
hydrophobic moieties in the binding is consistent with the observation that the
tight complex can only be dissociated by denaturation. The structure of Im3
resembles those of certain nucleic acid binding proteins, in particular domain II
of topoisomerase I and RNA-binding proteins that contain the ribonucleoprotein
(RNP) sequence motif. This observation suggests that Im3 has a nucleic acid
binding function in addition to binding colicin E3.
Introduction
Colicin E3 is a 58 kDa antibiotic-like protein that pene-
trates sensitive cells and kills them by inactivation of
their ribosomes [1]. Expression of colicin E3 is induced
by the SOS response under conditions that threaten the
survival of a bacterial population [2]. The secretion of a
toxin such as colicin E3 may be envisaged as a defense
mechanism against the rapid growth of related and com-
petitive bacterial species in the same ecological niche.
Translocation of colicin E3 across the bacterial cell enve-
lope of the producing organism and release into the extra-
cellular space requires expression of the bacteriocin
release protein gene [3]. Colicin E3 is able to penetrate
the cell envelope of a sensitive host as well as its cytoplas-
mic membrane. The first step in the invasion of the host
is the binding to the outer membrane BtuB receptor,
which is involved in vitamin B12 uptake into Escherichia
coli [4–7]. Subsequent translocation across the plasma
membrane involves the TolB protein [8]. Once inside the
cell, colicin E3 kills the host by inactivating its protein
biosynthetic machinery [9–11]. The mode of action in
vivo involves a single nucleolytic break of E. coli 16S ribo-
somal RNA (rRNA) at a specific site, 48 nucleotides from
the 3′-end [12–14]. The same cleavage has been observed
in vitro by incubation of isolated 70S ribosomes with puri-
fied colicin E3 [15,16]. Although only a single phospho-
diester bond is cleaved, and there is evidence that the
fragments stay attached to each other, the result is the
complete inactivation of the ribosome. 
The resistance of the producing organism towards its
own colicin E3 is due to the presence of the 9.8 kDa
‘immunity protein’ which forms a tight 1:1 complex with
colicin E3 [17,18] and renders it inactive [19]. The
immunity protein (Im3) thus acts as a specific RNase
inhibitor. Colicin E3 is secreted by the producing organ-
ism as a binary complex with Im3 [20]. The complex is
tight and can only be dissociated under denaturing con-
ditions [18]. Cys47, the single thiol in Im3, has been
implicated in the interaction with colicin E3 as the most
important specificity determinant [21]. The genes for
colicin E3 and Im3 have been cloned and sequenced
[22]. Transcription of the colicin E3 operon is controlled
by the inducible SOS promoter upstream from the struc-
tural gene. As the  space between  the genes encoding
colicin E3 and the immunity protein consists of only nine
nucleotides [23], and Im3 is produced in large excess
over colicin E3, it has been postulated that a separate
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promoter for the transcription of Im3 may be contained
within the structural gene of colicin E3 [2].
Colicin E3 acts specifically on intact ribosomes that contain
all the ingredients required for protein biosynthesis. There-
fore, its three-dimensional structure is likely to reflect the
local conformation of the ribosome in the vicinity of the
cleavage site. We have undertaken the crystallographic
structure determination of colicin E3 and its immunity
protein in order to develop a structural basis for under-
standing the ribonucleolytic activity and its inhibition, as
well as to gain insight into the structure of the ribosome in
the vicinity of the 3′-end of 16S rRNA. Here we report the
crystal structure of free Im3 at 1.8 Å resolution. The struc-
ture suggests a colicin E3 binding site centered around
Cys47 that contains both polar and nonpolar moieties.
Results and discussion
Protein preparation
Im3 was isolated in free form as well as in a binary
complex with colicin E3. Free Im3 was obtained in huge
excess over bound Im3; large amounts are apparently pro-
duced to protect the producing cell from the toxicity of
endogenous or exogenous colicin E3. Free Im3 was used
in this study. No attempt was made to dissociate the
complex. Colicin E3 was found exclusively in the bound
form with Im3.
Crystallographic parameters and structure determination
Im3 was crystallized in the monoclinic space group C2 with
cell dimensions a = 80.07 Å, b = 53.72 Å, c = 36.25 Å and
β = 93.18°. There are two molecules per asymmetric unit.
The value of Vm, the crystal volume per unit molecular
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Table 1
Data collection statistics.
Compound Concentration (nM) Soaking time Resolution (Å) Reflections Completeness Rsym* Riso†
Native N/A N/A 1.80 11,860 0.81 (0.77) 0.044 (0.167) N/A
NaAuCl4 1 2 days 2.33 5554 0.83 (0.38) 0.10 0.22 (0.27)
TMLA 20 26 h 2.33 5789 0.87 (0.42) 0.06 0.13 (0.15)
TELCL1 20 5 days 2.33 5500 0.82 (0.41) 0.06 0.12 (0.14)
TELCLl2 30 5 days 2.33 5602 0.85 (0.40) 0.06 0.17 (0.24)
AgNO3 1 18 h 2.33 6063 0.87 (0.41) 0.05 0.19 (022)
TMLA, trimethyllead acetate; TELCL, triethyllead chloride. Values in
parentheses are for the outermost resolution shell: 1.88–1.80 Å for
native, 2.45–2.33 Å for the derivatives. *Rsym = ΣI–Iav/ΣIav, where I
is the intensity and Iav the average intensity. Riso = ΣIder–Inat/ΣInat,
where Inat is the intensity of the native and Ider the intensity of the
derivative.
Table 2
Multiple isomorphous replacement statistics (10–2.5 Å). 
Derivative Site No. x y z B* Relative Relative Phasing Rcullis‡ Figure
occupancy anomalous power† of merit
occupancy
NaAuCl4 1 0.239 0.000 0.212 25.32 0.80 N/A 1.70 0.70
2 0.253 –0.078 0.340 21.25 0.66 N/A
TMLA 1 0.388 –0.072 0.460 25.34 0.44 0.34 1.32 0.78
2 0.186 0.111 0.269 24.88 0.17 0.17
3 0.301 0.005 0.497 27.13 0.17 0.14
TELCL1 1 0.387 –0.068 0.470 24.46 0.41 N/A 2.25 0.58
2 0.171 0.196 0.187 26.96 0.43 N/A
3 0.348 0.338 0.020 31.15 0.13 N/A
TELCL2 1 0.388 –0.069 0.470 22.98 0.50 0.23 1.75 0.68
2 0.171 0.196 0.188 26.43 0.59 0.22
AgNO3 1 0.245 0.000 0.202 24.83 0.85 N/A 1.53 0.73
2 0.252 –0.082 0.345 21.52 0.78 N/A 0.72
TMLA, trimethyllead acetate; TELCL1, triethyllead chloride, data set 1;
TELCL2, triethyllead chloride, data set 2. *B, temperature factor.
†Phasing power = rms fh/E, where fh is the heavy-atom structure-factor
amplitude and E is the residual lack of closure error. ‡Rcullis = ∑εiso/∑∆iso,
where εiso is the lack of closure and ∆iso the isomorphous difference. Both
phasing power and Rcullis are for acentric data.
weight, is 1.99 Å3 Da–1, which corresponds to a solvent
content of 37% (v/v). The crystal structure of Im3 was
determined by multiple isomorphous replacement (MIR)
phasing using four heavy-atom derivatives, followed by
solvent flattening and noncrystallographic symmetry (NCS)
averaging of the electron density of the two molecules in
the asymmetric unit (Tables 1,2). The structure was
refined with all 11,860 reflections to a resolution of 1.8 Å;
the Rcryst and Rfree are 0.217 and 0.264, respectively. The
Rfree was calculated for a randomly selected 10% subset of
the reflections not used in the structure refinement. There
are no residues in disallowed regions of the Ramachandran
plot, and the stereochemistry is good (Table 3). The model
includes all 84 residues in each of the two subunits of the
asymmetric unit, 129 water molecules and one zinc ion.
Molecular structure
The secondary structure of Im3 consists of a four-stranded
antiparallel β sheet flanked by three α helices on one side
of the sheet (Figures 1,2). The topology is ββααβαβ with
the following residues in secondary structural elements:
β1, residues 2–10; β2, 16–21; α1, 30–35; α2, 38–43; β3,
47–49; α3, 52–61; β4, 71–79. The long loop between β2
and β3 harbors two short helical segments interrupted by a
glycine–valine sequence. The third helix is part of the
long loop connecting strands β3 and β4. The first and last
three residues of this helix have dihedral angles corre-
sponding to a 310 helix. 
The quaternary structure
The asymmetric unit consists of two molecules related by
a noncrystallographic twofold axis. The root mean square
deviation (rmsd) between corresponding atoms in the two
molecules of the asymmetric unit is 0.66, 0.71 and 1.13 Å
for Cα, backbone and all atoms, respectively. The largest
discrepancies occur at the C termini as well as at the
subunit interface. The C termini are located on the surface
in regions that exhibit relatively poor electron density.
Upon completion of the chain tracing for both molecules
and accounting for all protein atoms, a high peak of 30
standard deviations above the mean was found in the
Fo–Fc difference map. This peak was located on the local
dyad between the thiols of Cys47 from both molecules.
This peak was interpreted as a zinc ion that cross-links the
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Table 3
Validation parameters.
Average B factor for buried atoms (Å2) 18.83
Average B factor for all atoms (Å2) 23.29
Rms deviations from ideal values
Bond lengths (Å) 0.006
Bond angles (°) 1.306
Dihedral angles (°) 24.41
Improper torsion angles (°) 0.587
Ramachandran plot
Residues in most favored regions (%) 87.7
Residues in additional allowed regions (%) 10.3
Residues in generously allowed regions (%) 2.1
Average B factors and root mean square (rms) deviations from ideal
values were calculated with CNS [42]. The Ramachandran plot was
calculated with the program PROCHECK [46].
Figure 1
Stereoview Cα trace of Im3. The third
residue and every tenth residue thereafter are
labeled. The N and C termini are indicated.
(This figure was made with the program
MOLSCRIPT [43].)
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Structure
two polypeptide chains by forming covalent bonds to the
two thiols. The Zn–S distances are 2.59 and 2.66 Å, respec-
tively (Figure 3). The presence of zinc ions was estab-
lished by inductively coupled plasma mass spectroscopy
(see the Materials and methods section). As no zinc ions
were added during the protein purification or crystalliza-
tion, the zinc ions must have been abstracted from the
medium by Im3 during bacterial growth. 
Molecular interface 
The zinc cross-link constitutes the major interaction
between the subunits. Additional interactions include
two hydrogen bonds between molecules A and B (AGlu14
O–BAsn44 Nδ2 [2.7 Å] and APhe16 N–BTyr79 O
[2.84 Å]) as well as hydrophobic interactions involving
nonpolar atoms in nine residues from monomer A (Phe9,
Glu14, Asp15, Phe16, Asn44, Asn45, Gly46, Phe74 and
Arg80) and seven residues from monomer B (Phe9′,
Phe16′, Asn44′, Cys47′, Phe74′, Tyr79′ and Arg80′;
Figure 3). Furthermore, there are two water molecules
located at the interface. 
It is unclear whether the zinc-mediated dimerization is of
biological importance or whether it is an artifact caused by
the conditions used for the purification and crystallization
of Im3. As Cys47 is essential for binding to colicin E3, it is
reasonable to assume that the Im3 dimer has to dissociate
into monomers before binding colicin E3. Dissociation of
the dimer could be facilitated by the reducing environ-
ment inside the cell or by a drop in the pH. Dimerization
might be a way to protect Im3 from proteolysis and keep it
in an inactive form until it is needed. A similar mechanism
has been observed for insulin. In this case oligomerization
has been shown to be an effective way of preserving the
protein in an inactive form [24].
Comparison with the NMR structure
A solution nuclear magnetic resonance (NMR) structure
of Im3 has been reported [25]. A detailed comparison of
the Im3 crystal structure with the solution structure is not
possible as the coordinates for the solution structure have
not been deposited in the Protein Data Bank. However,
the four-stranded antiparallel β sheet is common to both
the crystal and solution structures, but there is a differ-
ence in the helical content. Based on the published Cα
stereodiagram and the accompanying text, there is only a
single helix in the solution structure, located between
strands 2 and 3. This helix corresponds to α3 in the
crystal structure. Although stretches α1 and α2 in the
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Figure 2
Ribbon diagram of the Im3 monomer. The structure consists of a four-
stranded antiparallel β sheet flanked by three α helices on one side of
the sheet. The long loop connecting strands β2 and β3 contains two
helical stretches α1 and α2. The longest helix, α3, forms part of the
connection between β3 and β4. (This figure was made with the
programs MOLSCRIPT [43] and RASTER3D [44].)
Figure 3
The molecular interface of the Im3 dimer. Monomers A and B are
depicted as Cα traces. Residues at the interface are shown in
ball-and-stick representation in green (monomer A) and blue (monomer
B). A major intermolecular interaction is the covalent cross-link of the
thiols via a zinc ion, shown in yellow. Additional interactions include
two intermolecular hydrogen bonds as well as hydrophobic
interactions involving the nonpolar atoms of nine residues from
monomer A, and seven residues from monomer B (see text).
Furthermore, there are two water molecules, shown in red, that
mediate the interaction between the monomers. (This figure was made
with the program MOLSCRIPT [43].)
crystal structure are rather short, we nevertheless classify
them as helices as they contain at least one helical hydro-
gen bond in addition to having helical dihedral angles φ
and ψ. Another difference between the crystal and solu-
tion structures is in the quaternary structure. The mater-
ial we used for crystallization is dimeric, as determined by
gel chromatography on Sephadex G-75 [26]. Although the
authors of the NMR structure do not comment on the
quaternary state of the protein, one may assume it was
monomeric, otherwise they would have indicated the
quaternary structure. The reason for this discrepancy
between the crystal and solution structures is not known.
It is possible that the material used for the NMR studies
did not contain any zinc ions, which constitute the main
interaction between the two monomers of the crystal
structure. In this context it is noteworthy that 15N-labeled
Im3 for NMR experiments was prepared by dissociation
of the binary complex with colicin E3 in 6 M urea [27]. In
contrast, the material used for the crystal structure deter-
mination is free uncomplexed Im3.
A putative colicin-binding surface
Asp5, Glu19 and Cys47 have previously been implicated
in the interaction with colicin E3 [27]. These three
residues are located on the dimer interface of the Im3
crystal structure. In a binary complex with colicin E3 these
residues would be available to interact with colicin E3.
Other nearby polar residues include Thr7, Glu14, Tyr21,
Asp45, Asp49, Glu53, Glu72, Ser76 and Asp78. These
residues form part of a binding surface which also contains
the three phenylalanine sidechains of residues 9, 16 and 74
as well as Cys47. This cleft represents a likely interaction
site with colicin E3 (Figure 4). The involvement of non-
polar interactions in complex formation is consistent with
the observation that the complex cannot be dissociated by
varying the pH or ionic strength. The only known way to
dissociate the complex is by denaturation in 6 M urea [18].
The binding constant between Im3 and colicin E3 has not
been measured, but it is likely to be high. In the case of
colicin E9 and its immunity protein the dissociation con-
stant has been determined to be 9.3 × 10–17 M–1 [28], most
probably representing the most stable protein–protein
complexes ever observed. This affinity corresponds to a
free energy change of –22 kcal mol–1 at 25°C.
Comparison with other colicin immunity protein structures
The structures of the immunity proteins for colicin E7 and
E9 are known. Both these colicins act as nonspecific
DNases. The crystal structure of Im7 is an antiparallel four-
helical bundle [29]. Likewise, the solution structure of Im9
is a distorted antiparallel helical bundle [30]. The structures
of these immunity proteins bear no resemblance to Im3.
Similarity to other known protein structures
A similarity search of the Im3 monomer fold against a
database of known protein structures was carried out at
the DALI server [31]. A significant similarity was found to
domain II of topoisomerase I from E. coli (PDB code 1ecl)
[32]. This domain is composed of a three-stranded antipar-
allel β sheet and a single helix. One side of this sheet
forms part of the DNA-binding site in topoisomerase I.
The helix is located on the other side of the sheet, point-
ing to the exterior. Strands β1, β2 and β4, as well as helix
α1 of Im3, superimpose on domain II of topoisomerase I
with an rmsd of 2.1 Å for 44 common Cα atoms. A similar
topology is also found for small RNA-binding proteins
which contain the RNP sequence motifs, such as the U1A
spliceosomal protein [33,34]. The hallmark of these pro-
teins is a four-stranded antiparallel β sheet flanked by two
or three helices on one side of the sheet. Here again,
strands β1, β2 and β4 align well with three of the strands
in the U1A-binding protein. The rmsd of the 20 corre-
sponding Cα atoms in the β strands is 1.0 Å. Superposition
of Im3 on domain II of topoisomerase I or on the RNA-
binding region of the U1A-binding protein suggests that
Im3 may have a nucleic acid binding region on the side of
the sheet opposite to the helices. In the vicinity of the
spatially close N and C termini there are two basic
residues, Lys3 and Arg80, which could be involved in
binding to nucleic acid. The nearby C-terminal Trp84
might also have a role in nucleic-acid binding. The puta-
tive colicin E3 binding surface is centered around Cys47
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Figure 4
Surface representation of the Im3 monomer showing two putative
binding surfaces, one for colicin E3 and the other for a nucleic acid.
Negatively and positively charged regions are shown in red and blue,
respectively. The putative binding pocket for colicin E3 is centered
around Cys47 and includes the following residues: Asp5, Thr7, Phe9,
Glu14, Phe16, Glu19, Tyr21, Asp45, Cys47, Asp49, Glu53, Glu72,
Phe74, Ser76 and Asp78. Residues involved in nucleic acid binding
may include Lys3, Arg80 and Trp84. In this view the molecule is
rotated by roughly 180° about a horizontal axis from the orientation of
monomer A shown in Figure 3. (This figure was made with the program
GRASP [45].)
on strand β3, which is unique and has no counterpart in
topoisomerase I or in the U1A-binding protein. According
to this hypothesis, Im3 would have two different binding
surfaces, one for colicin E3 and another for a nucleic acid,
perhaps rRNA (Figure 4). This suggests that Im3 might
have a nucleic acid binding function in addition to its
function of inhibiting colicin E3.
The only other structural similarity found by the DALI
search was to the calcium-phospholipid-binding domain
of cytosolic phospholipase A2 (PDB code 1rlw) [35].
This protein forms an eight-stranded antiparallel β sand-
wich. Four of the strands superimpose on the corre-
sponding strands of Im3 with an rmsd of 2.9 Å for 49
common Cα atoms. As none of the helices in Im3 has
any counterpart in this structure, this similarity is not
considered significant.
Biological implications
Colicins are toxic proteins of Escherichia coli that kill
related strains by an enzymatic mode of action. Colicin
E3 acts as a very specific RNase that cleaves a single
phosphodiester bond in 16S rRNA between bases 48
and 49, counted from the 3′-end [11–13]. The ribosomes
of the host cell are inactivated by this cleavage and
protein biosynthesis is shut off [10]. An inhibitor tightly
bound to colicin E3, the immunity protein Im3, blocks
the action of colicin E3. 
The crystal structure of free Im3 suggests a binding
surface for colicin E3 which includes exposed hydropho-
bic residues as well as negatively charged and neutral
polar residues. This putative binding pocket is centered
around the residue Cys47 which has previously been
shown to be essential for activity [25]. The similarity of
the Im3 fold with some nucleic acid binding proteins sug-
gests a possible role for Im3 in RNA binding. 
Materials and methods
Protein preparation, crystallization and X-ray data collection
Im3 was prepared as previously described [36] following procedures of
Herschman and Helinski [37] and Jakes et al. [18] with slight modifica-
tions. Crystals were grown by vapor diffusion in hanging drops at room
temperature from solutions of ammonium sulfate. Large single crystals
were obtained by macroseeding from small but well-shaped crystallites
in the following way. Drops of 15 µl each, containing 5 mg ml–1 protein,
1.4 M ammonium sulfate, 80 mM sodium chloride, 33 mM MES buffer
pH 6.0, 5 µM sodium azide and 5 µM phenylmethanesulfonylfluoride
(PMSF) were inverted over a reservoir solution containing 2 M ammo-
nium sulfate, 100 mM MES buffer pH 6.0, 100 mM sodium chloride and
10 mM sodium azide. After 24–36 h the clear hanging drops were inoc-
ulated with small Im3 crystals, typically 0.1–0.3 mm long, which had
previously been obtained under similar conditions and longer times. The
seed crystals were washed three times in a solution containing 2 M
ammonium sulfate, 25 mM MES buffer pH 6.0, 100 mM sodium chlo-
ride and 10 mM sodium azide. Large single crystals, up to 1.5 mm long,
developed within one to two weeks.
X-ray data were collected at room temperature on a San Diego Multi-
wire dual area detector system mounted on a Rigaku RU200 rotating
anode generator operated at 50 kV and 100 mA. Data were processed
with the San Diego Multiwire software. 
Structure determination
Heavy-atom sites were determined by conventional difference Patter-
son and difference Fourier techniques carried out with the CCP4 suite
of crystallographic programs [38]. The handedness was determined
from the anomalous scattering of two of the derivatives. Phases were
calculated with program MLPHARE [39]. The resultant electron-density
map was improved by solvent flattening with the program DM [40]. A
preliminary chain trace was performed with program O [41] into this
2.5 Å map. Parts of two independent subunits were traced in the elec-
tron-density map. The coordinates of the two chains were used to
determine the matrix and vector relating the two molecules in the asym-
metric unit. Subsequent density modification by NCS averaging
resulted in a map in which all but the last four residues of each mole-
cule could be traced. At this point a peak of 30 standard deviations
above the mean was discovered in the Fo–Fc difference map. This peak
was located on the local twofold axis between the thiol groups of
Cys47 on each of the two molecules in the asymmetric unit; this peak
was interpreted as a zinc ion. The presence of zinc was later confirmed
by inductively coupled plasma mass spectroscopy. Incorporation of the
zinc ion improved the electron-density map in previously weak regions,
in particular the loop of residues 10–16 as well as the last four
residues (81–84). The resolution was subsequently extended to 1.8 Å,
and the model was refined by positional refinement and simulated
annealing with the programs X-PLOR and CNS [42]. Initially the NCS
was enforced strictly. During later cycles this condition was relaxed to
restraints with weights of 100 and 200 for backbone and sidechain
atoms, respectively. Finally, NCS restraints were completely lifted. The
position of the zinc ion was determined from the difference Fourier map
and it was refined without constraints. When Rcryst and Rfree dropped to
values of 0.23 and 0.27, respectively, water molecules were gradually
inserted into the model with the ‘waterpick’ routine in the program
CNS. The criteria for accepting a water molecule were a peak height of
at least three standard deviations above the mean in the Fo–Fc map,
good appearance in the 2Fo–Fc map and a refined temperature factor
of no more than 70 Å2. Figure 5 shows a typical portion of the 2Fo–Fc
electron-density map at 1.8 Å resolution.
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Figure 5
Portion of the 2Fo–Fc electron-density map at 1.8 Å resolution in the
region of strands β1, β2 and β4. The map is contoured at 1.0
standard deviations above the mean. The superimposed final model is
shown in ball-and-stick representation. (This figure was made with the
program O [41].)
Metal ion determination
A solution of Im3 from the same batch that had been used for crystal-
lization was analyzed for metal ion content by inductively coupled
plasma mass spectroscopy using a VG Elemental Plasmaquad2+
inductively coupled plasma mass spectrometer (VG Elemental,
Beverly, MA), equipped with a CETAT technologies U-6000 ultrasonic
nebulizer (CETAC Technologies, Omaha, NE). The metal ion detected
was Zn2+ at a concentration of 0.18 mM. The only other metal ion
found was a trace amount of Cu2+. As the protein concentration was
8 mg ml–1 or 0.41 mM of Im3 dimers, it follows that the amount of zinc
present in the solution is sufficient to occupy a site in 44% of the
dimers. The actual concentration of zinc in the crystals has not been
measured, as crystals were no longer available at the time the electron
density suggested the presence of a metal ion in the dimer interface.
Refinement of the Im3 crystal structure indicated one zinc ion per
dimer with a B factor of 6.2 Å2. 
Accession numbers
The atomic coordinates of Im3 have been deposited in the Protein Data
Bank with accession code 3eip.
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